Alter Todd H, Ilyas Asif M
Rothman Institute at the Thomas Jefferson University, Philadelphia, PA.
Rothman Institute at the Thomas Jefferson University, Philadelphia, PA.
J Hand Surg Am. 2017 Oct;42(10):810-815. doi: 10.1016/j.jhsa.2017.07.003. Epub 2017 Sep 8.
Prescription opioid misuse has become increasingly prevalent in the United States. Preoperative opioid counseling has been proposed to decrease opioid consumption after surgery. This study aimed to evaluate the effect of preoperative opioid counseling on patients' pain experience and opioid consumption after carpal tunnel release (CTR) surgery.
A prospective comparison of consecutive patients scheduled to undergo CTR surgery was conducted. Patients were randomized to receive either formal preoperative opioid counseling or no counseling. All operations were performed with the same mini-open CTR surgical technique, and the same number of opioids were prescribed after surgery. Daily opioid pill consumption, pain levels, and any adverse reactions were recorded.
During the day of surgery and the first day following surgery, patients in the group with counseling reported significantly fewer prescribed opioid pills consumed compared with patients in the group without counseling, while experiencing no significant difference in pain level experience. In addition, patients in the group with counseling reported a significantly lower number of total pain pills consumed over the course of the study than the group without counseling. No major adverse reactions were noted in either group.
Preoperative opioid counseling was found to result in a significant decrease in overall opioid consumption after surgery.
TYPE OF STUDY/LEVEL OF EVIDENCE: Therapeutic II.
处方类阿片药物滥用在美国日益普遍。术前阿片类药物咨询已被提议用于减少术后阿片类药物的使用量。本研究旨在评估术前阿片类药物咨询对腕管松解术(CTR)后患者疼痛体验和阿片类药物使用量的影响。
对计划接受CTR手术的连续患者进行前瞻性比较。患者被随机分为接受正式术前阿片类药物咨询组或不接受咨询组。所有手术均采用相同的小切口CTR手术技术,术后开具相同数量的阿片类药物。记录每日阿片类药物片消耗量、疼痛程度及任何不良反应。
在手术当天及术后第一天,接受咨询组患者报告的阿片类药物处方消耗量明显少于未接受咨询组患者,而疼痛程度体验无显著差异。此外,在研究过程中,接受咨询组患者报告的总止痛片消耗量明显低于未接受咨询组。两组均未观察到重大不良反应。
术前阿片类药物咨询可使术后阿片类药物总消耗量显著降低。
研究类型/证据水平:治疗性II级。